NCT00685802View on ClinicalTrials.gov

Fasted Bioavailability Study of Cilostazol Tablets, 50mg

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Therapeutic Equivalency, Healthy
Interventions
DRUG

Cilostazol 50 mg Tablets

Cilostazol (2 x 50 mg tablets) administered after an overnight fast of at least 10 hours

DRUG

Cilostazol (Pletal®) 50 mg Tablets

Cilostazol (Pletal® Tablets, 2 x 50mg) administered after an overnight fast of at least 10 hours.

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00685802 - Fasted Bioavailability Study of Cilostazol Tablets, 50mg | Biotech Hunter | Biotech Hunter